Acute pulmonary vasodilator testing with inhaled treprostinil in children with pulmonary arterial hypertension

Pediatric Cardiology

Volumn 34, Issue 4, 2013, Pages 1006-1012

  Takatsuki, Shinichi ^a   Parker, Donna K ^b   Doran, Aimee K ^c   Friesen, Robert H ^a   Ivy, D Dunbar ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL COLORADO   (United States)

^c UNITED THERAPEUTICS CORPORATION   (United States)

Author keywords

Acute pulmonary vasodilator testing; Children; Iloprost; Inhaled treprostinil; Nitric oxide; Pulmonary arterial hypertension

Indexed keywords

NITRIC OXIDE; OXYGEN; TREPROSTINIL;

ACUTE PULMONARY VASODILATOR TESTING; ADOLESCENT; ARTICLE; BREATHING; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL EVALUATION; COHORT ANALYSIS; CONGENITAL HEART DISEASE; COUGHING; DISEASE ASSOCIATION; DIZZINESS; ENDOTRACHEAL INTUBATION; FEMALE; HEART CATHETERIZATION; HEMODYNAMIC PARAMETERS; HUMAN; HYPOTENSION; IDIOPATHIC DISEASE; INTERSTITIAL LUNG DISEASE; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; MEDICAL PROCEDURES; NEBULIZER; PRESCHOOL CHILD; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; SCHOOL CHILD;

ADMINISTRATION, INHALATION; ADOLESCENT; ANTIHYPERTENSIVE AGENTS; CHILD; CHILD, PRESCHOOL; EPOPROSTENOL; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; NITRIC OXIDE; OXYGEN; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 84879501455     PISSN: 01720643     EISSN: 14321971     Source Type: Journal    
DOI: 10.1007/s00246-012-0597-9     Document Type: Article

References (28)

1. Atz AM, Adatia I, Lock JE, Wessel DL (1999) Combined effects of nitric oxide and oxygen during acute pulmonary vasodilator testing. J Am Coll Cardiol 33:813-819
2. Barst RJ (1986) Pharmacologically induced pulmonary vasodilatation in children and young adults with primary pulmonary hypertension. Chest 89:497-503
3. Barst RJ, Maislin G, Fishman AP (1999) Vasodilator therapy for primary pulmonary hypertension in children. Circulation 99:1197-1208
4. Barst RJ, Agnoletti G, Fraisse A, Baldassarre J, Wessel DL (2010) Vasodilator testing with nitric oxide and/or oxygen in pediatric pulmonary hypertension. Pediatr Cardiol 31:598-606
5. Barst RJ, McGoon MD, Elliott CG, Foreman AJ, Miller DP, Ivy DD (2012) Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management. Circulation 125:113-122
6. Benza RL, Seeger W, McLaughlin VV, Channick RN, Voswinckel R, Tapson VF, Robbins IM, Olschewski H, Rubin LJ (2011) Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension. J Heart Lung Transplant 30:1327-1333
7. Bourge RC, Tapson VF, Safdar Z, Benza RL, Channick RN, Rosenzweig EB, Shapiro S, James White R, Shane McSwain C, Karl Gotzkowsky S, Nelsen AC, Rubin LJ (2012) Rapid transition from inhaled iloprost to inhaled treprostinil in patients with pulmonary arterial hypertension. Cardiovasc Therapeutics. doi: 10.1111/1755-5922.12008
8. Channick RN, Olschewski H, Seeger W, Staub T, Voswinckel R, Rubin LJ (2006) Safety and efficacy of inhaled treprostinil as add-on therapy to bosentan in pulmonary arterial hypertension. J Am Coll Cardiol 48:1433-1437
9. Doran AK, Ivy DD, Barst RJ, Hill N, Murali S, Benza RL (2008) Guidelines for the prevention of central venous catheter-related bloodstream infections with prostanoid therapy for pulmonary arterial hypertension. Int J Clin Pract Suppl 160:5-9
10. Douwes JM, van Loon RL, Hoendermis ES, Vonk-Noordegraaf A, Roofthooft MT, Talsma MD, Hillege HL, Berger RM (2011) Acute pulmonary vasodilator response in paediatric and adult pulmonary arterial hypertension: occurrence and prognostic value when comparing three response criteria. Eur Heart J
11. Hallioglu O, Dilber E, Celiker A (2003) Comparison of acute hemodynamic effects of aerosolized and intravenous iloprost in secondary pulmonary hypertension in children with congenital heart disease. Am J Cardiol 92:1007-1009
12. Ivy DD (2010) Prostacyclin in the intensive care setting. Pediatr Crit Care Med 11:S41-S45
13. Ivy D (2012) Advances in pediatric pulmonary arterial hypertension. Curr Opin Cardiol 27:70-81
14. Ivy DD, Claussen L, Doran A (2007) Transition of stable pediatric patients with pulmonary arterial hypertension from intravenous epoprostenol to intravenous treprostinil. Am J Cardiol 99:696-698
15. Ivy DD, Doran AK, Smith KJ, Mallory GB Jr, Beghetti M, Barst RJ, Brady D, Law Y, Parker D, Claussen L, Abman SH (2008) Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension. J Am Coll Cardiol 51:161-169
16. Ivy DD, Calderbank M, Wagner BD, Dolan S, Nyquist AC, Wade M, Nickels WM, Doran AK (2009) Closed-hub systems with protected connections and the reduction of risk of catheter-related bloodstream infection in pediatric patients receiving intravenous prostanoid therapy for pulmonary hypertension. Infect Control Hosp Epidemiol 30:823-829
17. Ivy DD, Rosenzweig EB, Lemarie JC, Brand M, Rosenberg D, Barst RJ (2010) Long-term outcomes in children with pulmonary arterial hypertension treated with bosentan in real-world clinical settings. Am J Cardiol 106:1332-1338
18. Krishnan U, Ivy DD, Takatsuki S, Kerstein J, Calderbank M, Rosenzweig EB (2012) Effectiveness and safety of inhaled treprostinil for the treatment of pulmonary arterial hypertension in children. Am J Cardiol 110(11):1704-1709
19. Lammers AE, Hislop AA, Flynn Y, Haworth SG (2007) Epoprostenol treatment in children with severe pulmonary hypertension. Heart 93:739-743
20. Levy M, Celermajer DS, Bourges-Petit E, Del Cerro MJ, Bajolle F, Bonnet D (2011) Add-on therapy with subcutaneous treprostinil for refractory pediatric pulmonary hypertension. J Pediatr 158:584-588
21. Limsuwan A, Khosithseth A, Wanichkul S, Khowsathit P (2009) Aerosolized iloprost for pulmonary vasoreactivity testing in children with long-standing pulmonary hypertension related to congenital heart disease. Catheter Cardiovasc Interv 73:98-104
22. McLaughlin VV, Oudiz RJ, Frost A, Tapson VF, Murali S, Channick RN, Badesch DB, Barst RJ, Hsu HH, Rubin LJ (2006) Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension. Am J Respir Crit Care Med 174:1257-1263
23. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J (2009) ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 53:1573-1619
24. McLaughlin VV, Benza RL, Rubin LJ, Channick RN, Voswinckel R, Tapson VF, Robbins IM, Olschewski H, Rubenfire M, Seeger W (2010) Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial. J Am Coll Cardiol 55:1915-1922
25. Rimensberger PC, Spahr-Schopfer I, Berner M, Jaeggi E, Kalangos A, Friedli B, Beghetti M (2001) Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms. Circulation 103:544-548
26. van Loon RL, Roofthooft MT, Delhaas T, van Osch-Gevers M, ten Harkel AD, Strengers JL, Backx A, Hillege HL, Berger RM (2010) Outcome of pediatric patients with pulmonary arterial hypertension in the era of new medical therapies. Am J Cardiol 106:117-124
27. Voswinckel R, Enke B, Reichenberger F, Kohstall M, Kreckel A, Krick S, Gall H, Gessler T, Schmehl T, Ghofrani HA, Schermuly RT, Grimminger F, Rubin LJ, Seeger W, Olschewski H (2006) Favorable effects of inhaled treprostinil in severe pulmonary hypertension: results from randomized controlled pilot studies. J Am Coll Cardiol 48:1672-1681
28. Yung D, Widlitz AC, Rosenzweig EB, Kerstein D, Maislin G, Barst RJ (2004) Outcomes in children with idiopathic pulmonary arterial hypertension. Circulation 110:660-665